Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Horizon Discovery and RIKEN GENESIS Sign Distribution Agreement

Published: Tuesday, July 16, 2013
Last Updated: Tuesday, July 16, 2013
Bookmark and Share
The agreement will see RIKEN GENESIS become sole distributor of Horizon’s molecular reference standards in Japan.

RIKEN GENESIS offers cutting-edge genomic products and services to a wide range of research institutions and corporations, and is a CAP (College of American Pathologists) accredited laboratory for genome analysis services. 

Reliable and renewable sources of reference standards are essential for molecular laboratories; however a lack of availability has previously been a major obstacle.  Even when patient samples are available, variability in DNA extraction and a lack of standardization have proven to be additional serious sources of error. Horizon’s HDx division has developed reliable and renewable genetically defined and thoroughly validated reference materials, providing an industry standard for the development of and quality control of molecular assays, thereby directly improving their accuracy.

Horizon’s Molecular Reference Standards include FFPE cell line blocks and purified gDNA. In early 2013 HDx launched its first Quantitative Multiplex DNA Reference Standard, intended for researchers assessing multiple biomarkers in a single assay, using platforms such as next generation sequencing (NGS).

“Part of our mission at RIKEN GENESIS is to contribute to translating the results of genetic research into clinical settings,” said Yusuke Tsukahara, President and CEO, RIKEN GENESIS. “Horizon’s Molecular Reference Standards are a valuable step in the move towards practical implementation of personalized medicine, and we are delighted to be working with such a forward looking company.” 

“At the cutting edge of genome analysis, RIKEN GENESIS is an ideal partner for Horizon. We aim to affiliate ourselves with the best, like-minded companies for distribution; those dedicated to customer service, cutting edge science and ultimately better patient care,” commented Dr Brian Burke, Business Development Manager, Horizon Diagnostics. “We look forward to working with the team to develop the molecular reference standards market in Japan.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Horizon Partners with EMQN
Horizon to provide genetically defined human genomic reference standards for cancer diagnostics proficiency testing schemes.
Tuesday, March 27, 2012
Horizon and UK NEQAS ICC Announce Partnership to Improve Accuracy of Lung Cancer Diagnostic Testing
Horizon’s genetically defined human genomic reference standards to be used in FISH and IHC proficiency testing to help guide personalised medicine.
Tuesday, January 31, 2012
Scientific News
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Toxin from Salmonid Fish has Potential to Treat Cancer
Researchers from the University of Freiburg decode molecular mechanism of fish pathogen.
Study Finds Non-Genetic Cancer Mechanism
Cancer can be caused solely by protein imbalances within cells, a study of ovarian cancer has found.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Tracking Breast Cancer Before it Grows
A team of scientists led by University of Saskatchewan researcher Saroj Kumar is using cutting-edge Canadian Light Source techniques to screen and treat breast cancer at its earliest changes.
DNA Damage Seen in Patients Undergoing CT Scanning
Along with the burgeoning use of advanced medical imaging tests over the past decade have come rising public health concerns about possible links between low-dose radiation and cancer.
The Mystery of the Instant Noodle Chromosomes
Researchers from the Lomonosov Moscow State University evaluated the benefits of placing the DNA on the principle of spaghetti.
Oxitec ‘Self-Limiting Gene’ Offers Hope for Controlling Invasive Moth
A new pesticide-free and environmentally-friendly way to control insect pests has moved ahead with the publication of results showing that Oxitec diamondback moths (DBM) with a ‘self-limiting gene’ can dramatically reduce populations of DBM.
Web App Helps Researchers Explore Cancer Genetics
Brown University computer scientists have developed a new interactive tool to help researchers and clinicians explore the genetic underpinnings of cancer.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!